381 results
8-K
EX-10.1
LFCR
Lifecore Biomedical Inc
14 May 24
Entry into a Material Definitive Agreement
5:04pm
paid or payable (A) to Ernst & Young LLP in respect of overages incurred in connection with its Fiscal Year 2021 audit of Holdings and its Subsidiaries … thereof under any Debtor Relief Laws, including those relating to (a) any audit, inspection, repossession, storage, repair, appraisal, insurance
8-K
LFCR
Lifecore Biomedical Inc
30 Apr 24
Changes in Registrant's Certifying Accountant
5:06pm
4.01 Changes in Registrant’s Certifying Accountant.
On April 29, 2024, the Audit Committee of the Board of Directors of Lifecore Biomedical, Inc … , to perform audit services for the fiscal year ending May 26, 2024.
During the two most recent fiscal years ended May 28, 2023 and May 29, 2022
NT 10-Q
LFCR
Lifecore Biomedical Inc
8 Apr 24
Notice of late quarterly filing
4:25pm
, 2024. The Company and its Audit Committee have initiated discussions with other independent registered public accounting firms in order to engage a new
8-K
EX-99.1
LFCR
Lifecore Biomedical Inc
1 Apr 24
Results of Operations and Financial Condition
8:07am
estimates, including as a result of audit adjustments and other developments that may arise between now and the time our actual consolidated financial
8-K
EX-99.2
LFCR
Lifecore Biomedical Inc
1 Apr 24
Results of Operations and Financial Condition
8:07am
financial results for the Historical Periods may differ materially from these preliminary estimates, including as a result of audit adjustments and other … leads to excellent regulatory record. ~80 customer audit days routinely held annually. 40+ years of a strong track record with global regulatory bodies
8-K
ci4 jbeeg
26 Mar 24
Changes in Registrant's Certifying Accountant
4:32pm
8-K
o03l typj8wuidb69
31 Oct 23
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
6:17am
8-K
EX-99.1
ri55jbeyltspk7rmuj
31 Aug 23
Results of Operations and Financial Condition
7:39am
424B3
uz2m9
9 Jun 23
Prospectus supplement
4:31pm
8-K
EX-99.1
hn3269
1 Jun 23
Lifecore Biomedical Reports Third Quarter Fiscal Year 2023 Results
7:29am
8-K
EX-10.1
pd6ul
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-10.3
y9jnfnxv1h 65j
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm